In-vivo Fourier domain optical coherence tomography as a new tool for investigation of vasodynamics in the mouse model

被引:12
作者
Meissner, Sven
Mueller, Gregor [1 ]
Walther, Julia
Morawietz, Henning [1 ]
Koch, Edmund
机构
[1] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Vasc Endothelium & Microcirculat, D-01307 Dresden, Germany
关键词
vasodynamics; Fourier domain optical coherence tomography; atherosclerosis; ATHEROSCLEROSIS; MOTION;
D O I
10.1117/1.3149865
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In-vivo imaging of the vascular system can provide novel insight into the dynamics of vasoconstriction and vasodilation. Fourier domain optical coherence tomography (FD-OCT) is an optical, non-contact imaging technique based on interferometry of short-coherent near-infrared light with axial resolution of less than 10 mu m. In this study, we apply FD-OCT as an in-vivo imaging technique to investigate blood vessels in their anatomical context using temporally resolved image stacks. Our chosen model system is the murine saphenous artery and vein, due to their small inner vessel diameters, sensitive response to vasoactive stimuli, and advantageous anatomical position. The vascular function of male wild-type mice (C57BL/6) is determined at the ages of 6 and 20 weeks. Vasoconstriction is analyzed in response to dermal application of potassium (K+), and vasodilation in response to sodium nitroprusside (SNP). Vasodynamics are quantified from time series (75 sec, 4 frames per sec, 330 x 512 pixels per frame) of cross sectional images that are analyzed by semiautomated image processing software. The morphology of the saphenous artery and vein is determined by 3-D image stacks of 512 x 512 x 512 pixels. Using the FD-OCT technique, we are able to demonstrate age-dependent differences in vascular function and vasodynamics. (C) 2009 Society of Photo-Optical Instrumentation Engineers. [DOI: 10.1117/1.3149865]
引用
收藏
页数:6
相关论文
共 18 条
[1]   Techniques to study the pharmacodynamics of isolated large and small blood vessels [J].
Angus, JA ;
Wright, CE .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (02) :395-407
[2]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[3]  
Chang Cheng-Jen, 2003, Chang Gung Med J, V26, P403
[4]   Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling - Molecular, cellular, and vascular behavior [J].
Chatzizisis, Yiannis S. ;
Coskun, Ahmet Umit ;
Jonas, Michael ;
Edelman, Elazer R. ;
Feldman, Charles L. ;
Stone, Peter H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (25) :2379-2393
[5]   CORONARY PLAQUE DISRUPTION [J].
FALK, E ;
SHAH, PK ;
FUSTER, V .
CIRCULATION, 1995, 92 (03) :657-671
[6]  
Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI 10.2184/lsj.31.635
[7]  
GAEHTGENS P, 2001, LEHRBUCH PHYL, P145
[8]   Commentary: Lifelong prevention of atherosclerosis: the critical importance of major risk factor exposures [J].
Greenland, P ;
Gidding, SS ;
Tracy, RP .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (06) :1129-1134
[9]  
Häusler G, 1998, J BIOMED OPT, V3, P21, DOI 10.1117/1.429899
[10]   Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer [J].
Hansma, AHG ;
Broxterman, HJ ;
van der Horst, I ;
Yuana, Y ;
Boven, E ;
Giaccone, G ;
Pinedo, HM ;
Hoekman, K .
ANNALS OF ONCOLOGY, 2005, 16 (10) :1695-1701